Proteinase 3 carries small unusual carbohydrates and associates with αlpha-defensins

Journal of Proteomics

Volumn 75, Issue 5, 2012, Pages 1472-1485

  Zoega, Morten ^a   Ravnsborg, Tina ^b   Højrup, Peter ^b   Houen, Gunnar ^a,b   Schou, Christian ^a  

^a STATENS SERUM INSTITUT   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

defensin associations; 1 antitrypsin inhibitor; Glycosylation; Mass spectrometry; Neutrophil proteins; Proteinase 3

Indexed keywords

ALPHA 1 ANTITRYPSIN; ALPHA DEFENSIN; BETA DEFENSIN 1; CARBOHYDRATE; MONOCLONAL ANTIBODY; MYELOBLASTIN; OLIGOMER; PLASMA PROTEIN;

ARTICLE; CARBOHYDRATE ANALYSIS; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOBLOTTING; INHIBITION KINETICS; MASS SPECTROMETRY; NEUTROPHIL GRANULE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION; PROTEIN PURIFICATION; PROTEIN STRUCTURE; STRUCTURE ANALYSIS; WESTERN BLOTTING;

ALPHA-DEFENSINS; CARBOHYDRATE METABOLISM; CARBOHYDRATES; GLYCOSYLATION; HUMANS; MASS SPECTROMETRY; MYELOBLASTIN; NEUTROPHILS;

EID: 84856355387     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2011.11.019     Document Type: Article

References (76)

1. Hager M., Cowland J.B., Borregaard N. Neutrophil granules in health and disease. J Intern Med Jul. 2010, 268(1):25-34.
2. Borregaard N. Neutrophils, from marrow to microbes. Immunity Nov. 24 2010, 33(5):657-670.
3. Kjeldsen L., Sengelov H., Lollike K., Nielsen M.H., Borregaard N. Isolation and characterization of gelatinase granules from human neutrophils. Blood Mar. 15 1994, 83(6):1640-1649.
4. Faurschou M., Sorensen O.E., Johnsen A.H., Askaa J., Borregaard N. Defensin-rich granules of human neutrophils: characterization of secretory properties. Biochim Biophys Acta Aug. 19 2002, 1591(1-3):29-35.
5. Le-Cabec V., Cowland J.B., Calafat J., Borregaard N. Targeting of proteins to granule subsets is determined by timing and not by sorting: The specific granule protein NGAL is localized to azurophil granules when expressed in HL-60 cells. Proc Natl Acad Sci U S A Jun. 25 1996, 93(13):6454-6457.
6. Lominadze G., Ward R.A., Klein J.B., McLeish K.R. Proteomic analysis of human neutrophils. Methods Mol Biol 2006, 332:343-356.
7. Jethwaney D., Islam M.R., Leidal K.G., de Bernabe D.B., Campbell K.P., Nauseef W.M., et al. Proteomic analysis of plasma membrane and secretory vesicles from human neutrophils. Proteome Sci 2007, 5:12.
8. Theilgaard-Monch K., Porse B.T., Borregaard N. Systems biology of neutrophil differentiation and immune response. Curr Opin Immunol Feb. 2006, 18(1):54-60.
9. Faurschou M., Kamp S., Cowland J.B., Udby L., Johnsen A.H., Calafat J., et al. Prodefensins are matrix proteins of specific granules in human neutrophils. J Leukoc Biol Sep. 2005, 78(3):785-793.
10. Lehrer R.I., Lichtenstein A.K., Ganz T. Defensins: antimicrobial and cytotoxic peptides of mammalian cells. Annu Rev Immunol 1993, 11:105-128.
11. Lehrer R.I., Jung G., Ruchala P., Wang W., Micewicz E.D., Waring A.J., et al. Human alpha-defensins inhibit hemolysis mediated by cholesterol-dependent cytolysins. Infect Immun Sep. 2009, 77(9):4028-4040.
12. Dietrich D.E., Xiao X., Dawson D.V., Belanger M., Xie H., Progulske-Fox A., et al. Human alpha- and beta-defensins bind to immobilized adhesins from Porphyromonas gingivalis. Infect Immun Dec. 2008, 76(12):5714-5720.
13. Kohlgraf K.G., Pingel L.C., Dietrich D.E., Brogden K.A. Defensins as anti-inflammatory compounds and mucosal adjuvants. Future Microbiol Jan. 2010, 5(1):99-113.
14. Ganz T., Selsted M.E., Szklarek D., Harwig S.S., Daher K., Bainton D.F., et al. Defensins. Natural peptide antibiotics of human neutrophils. J Clin Invest Oct. 1985, 76(4):1427-1435.
15. Selsted M.E., Harwig S.S., Ganz T., Schilling J.W., Lehrer R.I. Primary structures of three human neutrophil defensins. J Clin Invest Oct. 1985, 76(4):1436-1439.
16. Campopiano D.J., Clarke D.J., Polfer N.C., Barran P.E., Langley R.J., Govan J.R., et al. Structure-activity relationships in defensin dimers: a novel link between beta-defensin tertiary structure and antimicrobial activity. J Biol Chem Nov. 19 2004, 279(47):48671-48679.
17. Panyutich A., Ganz T. Activated alpha 2-macroglobulin is a principal defensin-binding protein. Am J Respir Cell Mol Biol Aug. 1991, 5(2):101-106.
18. Panyutich A.V., Hiemstra P.S., an Wetering S., Ganz T. Human neutrophil defensin and serpins form complexes and inactivate each other. Am J Respir Cell Mol Biol Mar. 1995, 12(3):351-357.
19. Panyutich A.V., Szold O., Poon P.H., Tseng Y., Ganz T. Identification of defensin binding to C1 complement. FEBS Lett Dec. 19 1994, 356(2-3):169-173.
20. Prohaszka Z., Nemet K., Csermely P., Hudecz F., Mezo G., Fust G. Defensins purified from human granulocytes bind C1q and activate the classical complement pathway like the transmembrane glycoprotein gp41 of HIV-1. Mol Immunol Aug. 1997, 34(11):809-816.
21. Selsted M.E., Ouellette A.J. Mammalian defensins in the antimicrobial immune response. Nat Immunol Jun. 2005, 6(6):551-557.
22. Ganz T., Selsted M.E., Lehrer R.I. Antimicrobial activity of phagocyte granule proteins. Semin Respir Infect Jun. 1986, 1(2):107-117.
23. Ganz T. Extracellular release of antimicrobial defensins by human polymorphonuclear leukocytes. Infect Immun Mar. 1987, 55(3):568-571.
24. Johansson B., Malm J., Persson T., Janciauskiene S., Andersson P., Carlson J., et al. Alpha-1-antitrypsin is present in the specific granules of human eosinophilic granulocytes. Clin Exp Allergy Mar. 2001, 31(3):379-386.
25. de Groot K., Gross W.L. Wegener's granulomatosis: disease course, assessment of activity and extent and treatment. Lupus 1998, 7(4):285-291.
26. Leavitt R.Y., Fauci A.S. Wegener's granulomatosis and other systemic granulomatous conditions. Curr Opin Rheumatol Feb. 1990, 2(1):55-59.
27. Leavitt R.Y., Fauci A.S., Bloch D.A., Michel B.A., Hunder G.G., Arend W.P., et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum Aug. 1990, 33(8):1101-1107.
28. Seo P., Stone J.H. The antineutrophil cytoplasmic antibody-associated vasculitides. Am J Med Jul. 1 2004, 117(1):39-50.
29. Reumaux D., Duthilleul P., Roos D. Pathogenesis of diseases associated with antineutrophil cytoplasm autoantibodies. Hum Immunol Jan. 2004, 65(1):1-12.
30. Goldschmeding R., Dolman K.M., van den Ende M.E., van der Meer-Gerritsen C.H., Sonnenberg A., von dem Borne A.E. The relation of 29 kD C-ANCA antigen to proteinase 3. APMIS Suppl 1990, 19:26-27.
31. Goldschmeding R., van der Schoot C.E., ten Bokkel H.D., Hack C.E., van den Ende M.E., Kallenberg C.G., et al. Wegener's granulomatosis autoantibodies identify a novel diisopropylfluorophosphate-binding protein in the lysosomes of normal human neutrophils. J Clin Invest Nov. 1989, 84(5):1577-1587.
32. Van der Woude F.J., Rasmussen N., Lobatto S., Wiik A., Permin H., van Es L.A., et al. Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet Feb. 23 1985, 1(8426):425-429.
33. van der Geld Y.M., Limburg P.C., Kallenberg C.G. Proteinase 3, Wegener's autoantigen: from gene to antigen. J Leukoc Biol Feb. 2001, 69(2):177-190.
34. Ohlsson K., Olsson I. The neutral proteases of human granulocytes. Isolation and partial characterization of granulocyte elastases. Eur J Biochem Mar. 1 1974, 42(2):519-527.
35. Wibisono D., Csernok E., Lamprecht P., Holle J.U., Gross W.L., Moosig F. Serum HMGB1 levels are increased in active Wegener's granulomatosis and differentiate between active forms of ANCA-associated vasculitis. Ann Rheum Dis Oct. 2010, 69(10):1888-1889.
36. Csernok E., Holle J.U., Gross W.L. Proteinase 3, protease-activated receptor-2 and interleukin-32: linking innate and autoimmunity in Wegener's granulomatosis. Clin Exp Rheumatol May 2008, 26(3 Suppl. 49):S112-S117.
37. Jiang B., Grage-Griebenow E., Csernok E., Butherus K., Ehlers S., Gross W.L., et al. The role of proteinase 3 (PR3) and the protease-activated receptor-2 (PAR-2) pathway in dendritic cell (DC) maturation of human-DC-like monocytes and murine DC. Clin Exp Rheumatol Jan. 2010, 28(1 Suppl. 57):56-61.
38. Csernok E., Ai M., Gross W.L., Wicklein D., Petersen A., Lindner B., et al. Wegener autoantigen induces maturation of dendritic cells and licenses them for Th1 priming via the protease-activated receptor-2 pathway. Blood Jun. 1 2006, 107(11):4440-4448.
39. Leid R.W., Ballieux B.E., van dH I., Kleyburg-van der Keur C., Hagen E.C., van Es L.A., et al. Cleavage and inactivation of human C1 inhibitor by the human leukocyte proteinase, proteinase 3. Eur J Immunol Nov. 1993, 23(11):2939-2944.
40. Novick D., Rubinstein M. The tale of soluble receptors and binding proteins: from bench to bedside. Cytokine Growth Factor Rev Oct. 2007, 18(5-6):525-533.
41. Novick D., Rubinstein M., Azam T., Rabinkov A., Dinarello C.A., Kim S.H. Proteinase 3 is an IL-32 binding protein. Proc Natl Acad Sci U S A Feb. 28 2006, 103(9):3316-3321.
42. Groutas W.C., Hoidal J.R., Brubaker M.J., Stanga M.A., Venkataraman R., Gray B.H., et al. Inhibitors of human leukocyte proteinase-3. J Med Chem Apr. 1990, 33(4):1085-1087.
43. Rao N.V., Wehner N.G., Marshall B.C., Gray W.R., Gray B.H., Hoidal J.R. Characterization of proteinase-3 (PR-3), a neutrophil serine proteinase. Structural and functional properties. J Biol Chem May 25 1991, 266(15):9540-9548.
44. Rao N.V., Wehner N.G., Marshall B.C., Sturrock A.B., Huecksteadt T.P., Rao G.V., et al. Proteinase-3 (PR-3): a polymorphonuclear leukocyte serine proteinase. Ann N Y Acad Sci 1991, 624:60-68.
45. Clemmensen S.N., Jacobsen L.C., Rorvig S., Askaa B., Christenson K., Iversen M., et al. Alpha-1-antitrypsin is produced by human neutrophil granulocytes and their precursors and liberated during granule exocytosis. Eur J Haematol Jun. 2011, 86(6):517-530.
46. van de Wiel B.A., Dolman K.M., van der Meer-Gerritsen C.H., Hack C.E., von dem Borne A.E., Goldschmeding R. Interference of Wegener's granulomatosis autoantibodies with neutrophil Proteinase 3 activity. Clin Exp Immunol Dec. 1992, 90(3):409-414.
47. van der Geld Y.M., Tool A.T., Videler J., de Haas M., Tervaert J.W., Stegeman C.A., et al. Interference of PR3-ANCA with the enzymatic activity of PR3: differences in patients during active disease or remission of Wegener's granulomatosis. Clin Exp Immunol Sep. 2002, 129(3):562-570.
48. Dolman K.M., Stegeman C.A., van de Wiel B.A., Hack C.E., von dem Borne A.E., Kallenberg C.G., et al. Relevance of classic anti-neutrophil cytoplasmic autoantibody (C-ANCA)-mediated inhibition of proteinase 3-alpha 1-antitrypsin complexation to disease activity in Wegener's granulomatosis. Clin Exp Immunol Sep. 1993, 93(3):405-410.
49. Sommarin Y., Rasmussen N., Wieslander J. Characterization of monoclonal antibodies to proteinase-3 and application in the study of epitopes for classical anti-neutrophil cytoplasm antibodies. Exp Nephrol Jul. 1995, 3(4):249-256.
50. Stummann L., Wiik A. A simple high yield procedure for purification of human proteinase 3, the main molecular target of cANCA. J Immunol Methods Aug. 7 1997, 206(1-2):35-42.
51. Heegaard N.H., Jakobsen D.R., Klattschou D. Purification of Wegener's granulomatosis autoantigen, proteinase 3, from neutrophils by Triton X-114 extraction of azurophilic granules. Anal Biochem Nov. 15 1997, 253(2):259-262.
52. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature Aug. 15 1970, 227(5259):680-685.
53. Shevchenko A., Wilm M., Vorm O., Mann M. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem Mar. 1 1996, 68(5):850-858.
54. Ravnsborg T., Houen G., Hojrup P. The glycosylation of myeloperoxidase. Biochim Biophys Acta Oct. 2010, 1804(10):2046-2053.
55. Specks U., Fass D.N., Finkielman J.D., Hummel A.M., Viss M.A., Litwiller R.D., et al. Functional significance of Asn-linked glycosylation of proteinase 3 for enzymatic activity, processing, targeting, and recognition by anti-neutrophil cytoplasmic antibodies. J Biochem Jan. 2007, 141(1):101-112.
56. Wilde C.G., Snable J.L., Griffith J.E., Scott R.W. Characterization of two azurphil granule proteases with active-site homology to neutrophil elastase. J Biol Chem Feb. 5 1990, 265(4):2038-2041.
57. Fujinaga M., Chernaia M.M., Halenbeck R., Koths K., James M.N. The crystal structure of PR3, a neutrophil serine proteinase antigen of Wegener's granulomatosis antibodies. J Mol Biol Aug. 16 1996, 261(2):267-278.
58. Panyutich A.V., Voitenok N.N., Lehrer R.I., Ganz T. An enzyme immunoassay for human defensins. J Immunol Methods Aug. 9 1991, 141(2):149-155.
59. Hill C.P., Yee J., Selsted M.E., Eisenberg D. Crystal structure of defensin HNP-3, an amphiphilic dimer: mechanisms of membrane permeabilization. Science Mar. 22 1991, 251(5000):1481-1485.
60. Wei G., Pazgier M., e Leeuw E., Rajabi M., Li J., Zou G., et al. Trp-26 imparts functional versatility to human alpha-defensin HNP1. J Biol Chem May 21 2010, 285(21):16275-16285.
61. Wei G., de Leeuw E., Pazgier M., Yuan W., Zou G., Wang J., et al. Through the looking glass, mechanistic insights from enantiomeric human defensins. J Biol Chem Oct. 16 2009, 284(42):29180-29192.
62. Lehrer R.I., Jung G., Ruchala P., Andre S., Gabius H.J., Lu W. Multivalent binding of carbohydrates by the human alpha-defensin, HD5. J Immunol Jul. 1 2009, 183(1):480-490.
63. van der Geld Y.M., Limburg P.C., Kallenberg C.G. Characterization of monoclonal antibodies to proteinase 3 (PR3) as candidate tools for epitope mapping of human anti-PR3 autoantibodies. Clin Exp Immunol Dec. 1999, 118(3):487-496.
64. Stratikos E., Gettins P.G. Formation of the covalent serpin-proteinase complex involves translocation of the proteinase by more than 70 A and full insertion of the reactive center loop into beta-sheet A. Proc Natl Acad Sci U S A Apr. 27 1999, 96(9):4808-4813.
65. Lee K.N., Im H., Kang S.W., Yu M.H. Characterization of a human alpha1-antitrypsin variant that is as stable as ovalbumin. J Biol Chem Jan. 30 1998, 273(5):2509-2516.
66. Korkmaz B., Attucci S., Hazouard E., Ferrandiere M., Jourdan M.L., Brillard-Bourdet M., et al. Discriminating between the activities of human neutrophil elastase and proteinase 3 using serpin-derived fluorogenic substrates. J Biol Chem Oct. 18 2002, 277(42):39074-39081.
67. Korkmaz B., Jaillet J., Jourdan M.L., Gauthier A., Gauthier F., Attucci S. Catalytic activity and inhibition of wegener antigen proteinase 3 on the cell surface of human polymorphonuclear neutrophils. J Biol Chem Jul. 24 2009, 284(30):19896-19902.
68. Korkmaz B., Poutrain P., Hazouard E., De Monte M., Attucci S., Gauthier F.L. Competition between elastase and related proteases from human neutrophil for binding to alpha1-protease inhibitor. Am J Respir Cell Mol Biol Jun. 2005, 32(6):553-559.
69. Kamdar K., Maemoto A., Qu X., Young S.K., Ouellette A.J. In vitro activation of the rhesus macaque myeloid alpha-defensin precursor proRMAD-4 by neutrophil serine proteinases. J Biol Chem Nov. 21 2008, 283(47):32361-32368.
70. Lehrer R.I., Jung G., Ruchala P., Wang W., Micewicz E.D., Waring A.J., et al. Human alpha-defensins inhibit hemolysis mediated by cholesterol-dependent cytolysins. Infect Immun Sep. 2009, 77(9):4028-4040.
71. Anthony D.A., Andrews D.M., Watt S.V., Trapani J.A., Smyth M.J. Functional dissection of the granzyme family: cell death and inflammation. Immunol Rev May 2010, 235(1):73-92.
72. Garwicz D., Lindmark A., Hellmark T., Gladh M., Jogi J., Gullberg U. Characterization of the processing and granular targeting of human proteinase 3 after transfection to the rat RBL or the murine 32D leukemic cell lines. J Leukoc Biol Jan. 1997, 61(1):113-123.
73. Campanelli D., Melchior M., Fu Y., Nakata M., Shuman H., Nathan C., et al. Cloning of cDNA for proteinase 3: a serine protease, antibiotic, and autoantigen from human neutrophils. J Exp Med Dec. 1 1990, 172(6):1709-1715.
74. Kam C.M., Kerrigan J.E., Dolman K.M., Goldschmeding R., von dem Borne A.E., Powers J.C. Substrate and inhibitor studies on proteinase 3. FEBS Lett Feb. 3 1992, 297(1-2):119-123.
75. Wysocka M., Lesner A., Guzow K., Kulczycka J., Legowska A., Wiczk W., et al. Highly specific substrates of proteinase 3 containing 3-(2-benzoxazol-5-yl)-l-alanine and their application for detection of this enzyme in human serum. Anal Chem May 1 2010, 82(9):3883-3889.
76. Korkmaz B., Attucci S., Moreau T., Godat E., Juliano L., Gauthier F. Design and use of highly specific substrates of neutrophil elastase and proteinase 3. Am J Respir Cell Mol Biol Jun. 2004, 30(6):801-807.